DePuy’s President Steps Down While Lawsuit Hearing Schedule Is Changed
Two events recently happened in the world of the DePuy ASR hip recall . The first is that DePuy president, David Floyd, was said by the company spokesperson, Mindy Tinsley, to have resigned. Floyd stated his reason was to “pursue outside interests.” He is expected to leave the company shortly but a replacement has not been announced.
Floyd’s reason for his departure leaves a lot to be desired. He has served office as president since 2007. It is probable that Floyd has already known of the issues associated with both the ASR XL Acetabular System and the ASR Hip Resurfacing System and their apparent failure among recipients. He did nothing. The United States Food and Drugs Administration received about four hundred reports from recipients complaining about how the ASRs have caused them pain and suffering. Only when the public knew of how defective the hip replacement were did DePuy recall the products. It wasn’t until August 2010 that DePuy recalled the hip replacements.
Eleven thousand recipients of the hip implants are said to need a revision surgery, out of the 93,000 units sold worldwide. Pain, limited or loss of mobility, dislocation, and metal toxicity resulting from metal debris getting flaked off from the device components are just some of the reported effects of having been implanted with the defective devices. Cobalt and chromium poisoning could result in nerve damage.
The other piece of news is that in a court order dated March 4, David A. Katz, the federal judge presiding over the DePuy multidistrict litigation (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products (no. 1:10 md 2197)), postponed a March 9 status conference to April 5. Both parties involved would then be givent the chance to present an extensive plan related to pretrial discovery. The status conference will occur at the U.S. Courthouse in West Palm Beach, Florida.
These recent developments prove the the DePuy litigation is starting to take off in a positive way, at least for those who wish to gain compensation from the company. Some of it may be too much for company officials to digest causing them to make hasty decisions. Whatever the case may be, recipients of the ASRs and their lawyers alike are bent on making DePuy be held liable for the harm the devices have inflicted. More information regarding the resignation of the DePuy president and the upcoming MDL conference is found at the hip replacement recall website.
If you enjoyed this post, make sure you subscribe to my RSS feed!
Leave a Reply